Seeking Alpha: NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp
NAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp
PE Hub: Archimed-backed Namsa picks up Labcorp’s early development medical testing biz
NAMSA has acquired select assets of Labcorp’s early development medical device testing business. The business acquisition aligns with Namsa’s strategy to broaden its service capabilities for medtech ...
A life sciences and health laboratory in Ann Arbor, Michigan, will be closed, with 76 jobs ending as a result. The Labcorp Ann Arbor Facility on Technology Drive, part of Labcorp Early Development ...
Developed with Amazon Web Services (AWS) and Datavant, Labcorp’s AI-powered platform delivers longitudinal laboratory data at scale with advanced analytics to accelerate discovery, streamline drug development, and improve patient outcomes.
The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the ...
Labcorp is a leading global life sciences company with a mission to improve health and improve lives. Combining world-class diagnostic solutions with its drug development business, our cutting-edge technologies, unparalleled data, and growing menu of standard and highly-specialized tests not only inform and empower patients and providers but help medical, biotech, and pharmaceutical companies ...
Seeking Alpha: Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw